Back to Search Start Over

Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper

Authors :
Hox, Valerie
Lourijsen, Evelijn
Jordens, Arnout
Aasbjerg, Kristian
Agache, Ioana
Alobid, Isam
Bachert, Claus
Boussery, Koen
Campo, Paloma
Fokkens, Wytske
Hellings, Peter
Hopkins, Claire
Klimek, Ludger
Makelä, Mika
Moesges, Ralph
Mullol, Joaquim
Pujols, Laura
Rondon, Carmen
Rudenko, Michael
Toppila-Salmi, Sanna
Scadding, Glenis
Scheire, Sophie
Tomazic, Peter-Valentin
Van Zele, Thibaut
Wagemann, Martin
van Boven, Job F. M.
Gevaert, Philippe
[Hox,V] Cliniques Universitaires Saint-Luc Brussels, Brussels, Belgium. [Lourijsen,E
Fokkens,W] Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, The Netherlands. [Jordens,A
Bachert,C
Van Zele,T
Gevaert,P] Upper Airway Research Laboratory, Dep. of Otorhinolaryngology, Ghent University Hospital, Ghent, Belgium. [Aasbjerg,K] Bispebjerg University Hospital, Copenhagen, Denmark. [Agache,I] Faculty of Medicine, Transsylvania University, Brasov, Romania. [Alobid,I
Mullol,J
Pujols,L] Hospital Clínic, IDIBAPS, CEBERES Universitat de Barcelona, Catalonia, Spain. [Alobid,I] Centro Medico Teknon, Barcelona, Spain. [Bachert,C] Department of Ear, Nose and Throat Diseases, Karolinska University Hospital, Stockholm, Sweden. [Boussery,K
Scheire,S] Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium. [Campo,P
Rondon,C] Allergy Unit, Hospital Regional Universitario of Málaga, IBIMA, ARADyAL, Malaga, Spain. [Hellings,P] Department of Ear, Nose and Throat Disease, University Hospitals, Louvain, Belgium. [Hopkins,C] ENT Department, Guy’s & St Thomas’ Hospital, London, UK. [Klimek,L] Center of Rhinology and Allergology, Wiesbaden, Germany. [Mäkelä,M
Toppila‑Salmi,S] Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. [Mösges,R] University of Cologne, Cologne, Germany. [Rudenko,M] London Allergy and Immunology Center, London, UK. [Scadding,G] Royal National Throat, Nose and Ear Hospital, London, UK. [Tomazic,PV] Medical University Graz, Graz, Austria. [Wagemann,M] Heinrich-Heine-University, Düsseldorf, Germany. [van Boven,JFM] Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, Groningen, The Netherlands.
This work was funded by an EAACI Task Force budget.
HUS Inflammation Center
Department of Dermatology, Allergology and Venereology
University of Helsinki
Publication Year :
2020
Publisher :
BioMed Central, Springer Nature, 2020.

Abstract

Correction: Volume: 10 Issue: 1 Article Number: 38 DOI: 10.1186/s13601-020-00343-w Published: SEP 28 2020 Because of the inflammatory mechanisms of most chronic upper airway diseases such as rhinitis and chronic rhinosinusitis, systemic steroids have been used for their treatment for decades. However, it has been very well documented that-potentially severe-side-effects can occur with the accumulation of systemic steroid courses over the years. A consensus document summarizing the benefits of systemic steroids for each upper airway disease type, as well as highlighting the potential harms of this treatment is currently lacking. Therefore, a panel of international experts in the field of Rhinology reviewed the available literature with the aim of providing recommendations for the use of systemic steroids in treating upper airway disease.

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.dedup.wf.001..591a9c85e7f291a7a925364f8e390280